Phase II trial of vorinostat in advanced melanoma. [electronic resource]
Producer: 20150207Description: 526-34 p. digitalISSN:- 1573-0646
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Biomarkers -- blood
- Disease-Free Survival
- Female
- Fibroblast Growth Factors -- blood
- Histone Deacetylase Inhibitors -- adverse effects
- Histones -- metabolism
- Humans
- Hydroxamic Acids -- adverse effects
- Male
- Melanoma -- drug therapy
- Middle Aged
- Polymorphism, Single Nucleotide
- Skin Neoplasms
- Tumor Suppressor Protein p53 -- genetics
- Vascular Endothelial Growth Factor A -- blood
- Vorinostat
- Melanoma, Cutaneous Malignant
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.